Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP6 | P51161 | 1/20 | 0.59 |
| ▸ | ATM | Q13315 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.58 |
| ▸ | MMP2 | P08253 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.57 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.57 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.45 |
| ▸ | METAP1 | P53582 | 2/20 | 0.45 |
| ▸ | METAP2 | P50579 | 1/20 | 0.45 |
| ▸ | CBFB | Q13951 | 1/20 | 0.45 |
| ▸ | AMY1A | P0DUB6 | 5/20 | 0.44 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10844887 | 0.91 | MAPT (0.50) | FABP6ATMMEN1MAPTKMT2A | |
| SCHEMBL23041368 | 0.84 | ATM (0.43) | FABP6ATMMEN1MAPTKMT2A | |
| SCHEMBL14502996 | 0.84 | MEN1 (0.43) | FABP6ATMMEN1MAPTKMT2A | |
| SCHEMBL2108252 | 0.84 | GRIN2D (0.44) | FABP6ATMMEN1MAPTKMT2A | |
| SCHEMBL9455942 | 0.81 | AMY1A (0.47) | FABP6ATMMEN1MAPTKMT2A | |
| SCHEMBL16134553 | 0.81 | MAPT (0.49) | FABP6ATMMEN1MAPTKMT2A | |
| SCHEMBL8314626 | 0.79 | TUBB4A (0.40) | FABP6ATMMEN1MAPTKMT2A | |
| SCHEMBL9261531 | 0.79 | TUBB4A (0.40) | FABP6ATMMEN1MAPTKMT2A | |
| SCHEMBL10846976 | 0.79 | MAPT (0.39) | FABP6ATMMEN1MAPTKMT2A | |
| SCHEMBL10606917 | 0.77 | HSD17B10 (0.41) | FABP6ATMMEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122051380-A | Application of additive in lithium battery electrolyte, electrolyte and lithium battery | 中国科学院大连化学物理研究所 | 2026-05-15 | — | — | CN | claimed |
| WO-2025071094-A1 | USES OF MERCAPTO FUNCTIONAL COMPOUND HAVING TYROSINASE INHIBITORY ACTIVITY | 부산대학교 산학협력단 | 2025-04-03 | — | — | WO | claimed |
| CN-122051380-A | Application of additive in lithium battery electrolyte, electrolyte and lithium battery | 中国科学院大连化学物理研究所 | 2026-05-15 | — | — | CN | disclosed |
| CN-120136899-A | Azo/deuterated imidazothiazinone compound, synthetic method and application | 新疆大学 | 2025-06-13 | — | — | CN | disclosed |
| WO-2025071094-A1 | USES OF MERCAPTO FUNCTIONAL COMPOUND HAVING TYROSINASE INHIBITORY ACTIVITY | 부산대학교 산학협력단 | 2025-04-03 | — | — | WO | disclosed |
| US-20240132479-A1 | THERAPEUTIC COMPOUNDS AND USES THEREOF | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2024-04-25 | — | — | US | disclosed |
| CN-114524829-B | Preparation method of imidazo [2,1-b ] thiazole derivative | 新疆大学 | 2024-04-02 | — | — | CN | disclosed |
| WO-2022165198-A1 | THERAPEUTIC COMPOUNDS AND USES THEREOF | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2022-08-04 | — | — | WO | disclosed |
| CN-114524829-A | Preparation method of imidazo [2,1-b ] thiazole derivative | 新疆大学 | 2022-05-24 | — | — | CN | disclosed |
| WO-2021038419-A1 | KINASE INHIBITORS AND METHODS OF SYNTHESIS AND TREATMENT | INSILICO MEDICINE IP LIMITED (CN) | 2021-03-04 | — | — | WO | disclosed |
| CN-111057269-A | 2-thiothiazolinyl or 2-thioimidazolinyl terminated mercaptosilane coupling agent and synthesis method and application thereof | 怡维怡橡胶研究院有限公司 | 2020-04-24 | — | — | CN | disclosed |
| US-4873237-A | ANTIULCER AGENTS | JOHN WYETH & BROTHER LIMITED (GB) | 1989-10-10 | — | — | US | disclosed |
| US-4772619-A | ANTIULCER AGENTS | G. D. SEARLE & CO. (US) | 1988-09-20 | — | — | US | disclosed |
| US-4687775-A | ANTIULCER AGENTS | G. D. SEARLE & CO. (US) | 1987-08-18 | — | — | US | disclosed |
| EP-0204215-A1 | 2-[(1H-benzimidazol-2-ylsulfinyl)methyl]-benzenamines | G.D. Searle & Co. (US) | 1986-12-10 | — | — | EP | disclosed |
| US-4608381-A | ANTIARTHRITIC AGENTS | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 1986-08-26 | — | — | US | disclosed |
| EP-0173664-A2 | Biologically active benzimidazole compounds and process for their preparation | Aktiebolaget Hässle (SE) | 1986-03-05 | — | — | EP | disclosed |
| EP-0129409-A2 | Thiazolo - and thiazinobenzimidazoles | JOHN WYETH & BROTHER LIMITED (GB) | 1984-12-27 | — | — | EP | disclosed |
| US-4017507-A | ANTIPYRETICS, VIRICIDES, ANTIANAPHYLACTIC SHOCK | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 1977-04-12 | — | — | US | disclosed |
| US-4000275-A | BENZIMIDAZO(2,1-B) QUINAZOLIN-12(6H)ONES | ELI LILLY AND COMPANY (US) | 1976-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240132479-A1 | THERAPEUTIC COMPOUNDS AND USES THEREOF | CUTA, DCXR, PLOD3 | FABP6 3186/4885ATM 3602/4885MEN1 2632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.